Article Details

Collaboration and Commitment hold the key for New Drug Development in India

Dr. Madhu Dikshit

FNA, FNASc, FASc, FAMS, JC Bose National Fellow THSTI National Chair, NCR Biotech Science Cluster 

Former Director,CSIR Central Drug Research Institute, Lucknow Former Visiting Professor, Department of Bioscience & Bioengineering, Indian Institute of Technology, Jodhpur-342037


ABSTRACT

Dr Madhu Dikshit is a leading scientist of the country and has made significant contributions to the general area of Molecular Pharmacology with special interest in redox biology. Dr Dikshit has impacted the area of neutrophil biology, by enhancing our understanding on how nitric oxide modulates neutrophil free radical generation, NETosis, chemotaxis, phagocytosis, apoptosis and also differentiation. She also initiated and led the team of anti-thrombotic drug discovery at CDRI, which has seen two of CDRI's anti-thrombotic molecules advancing to the pre-clinical stage. One of the molecules has reached the IND stage. Dr Dikshit has published more than 160 well cited papers in peer reviewed journals, has nine patents and has supervised more than 30 Ph.D., 10 MD theses, and has given training to more than 50 graduate students

Year 2019 | Volume No. 56 | Issue No.04 | Page No. 5-6
Recent Issue
Current Issue
August 2019
Quick Contact